Actuate Therapeutics, Inc. Common stock (ACTU) Stock price, Description, News & Info
#Thinksabio latest news Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh...
#Thinksabio latest news Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh...
#Thinksabio latest news Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301Regulatory...
#Thinksabio latest news Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global...
#Thinksabio latest news Tenable Expands Exposure Management Platform to Secure Enterprise AITenable AI Exposure gives...
#Thinksabio latest news AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in Key Presentations and...
#Thinksabio latest news VCI Global Appoints Dr. Chan as Chief AI & Data Officer to...
#Thinksabio latest news Bath & Body Works Launches in Over 600 College Campuses NationwideThe brand...
#Thinksabio latest news GitLab Signs Strategic Collaboration Agreement with AWS to Deliver Secure DevSecOps to...
#Thinksabio latest news Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase...
#Thinksabio latest news SailPoint Identity Security Cloud and IdentityIQ Achieve SAP® Certified Integration with RISE...